TNFSF10 and central nervous system cancer: Furthermore, the xenograft mice experiment showed the synergistic interaction between lestaurtinib and TRAIL wherein their coadministration more potently repressed tumour growth than these agents singly, indicating that the combination can be a robust option for human glioma treatment.